1. Home
  2. AZTA vs HROW Comparison

AZTA vs HROW Comparison

Compare AZTA & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$38.27

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$47.24

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTA
HROW
Founded
1978
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
AZTA
HROW
Price
$38.27
$47.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$43.20
$68.86
AVG Volume (30 Days)
685.2K
616.6K
Earning Date
02-04-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$593,821,000.00
$250,042,000.00
Revenue This Year
$6.13
$38.96
Revenue Next Year
$5.29
$43.38
P/E Ratio
N/A
N/A
Revenue Growth
3.55
47.83
52 Week Low
$23.91
$20.85
52 Week High
$55.64
$54.85

Technical Indicators

Market Signals
Indicator
AZTA
HROW
Relative Strength Index (RSI) 68.86 47.53
Support Level $36.86 $46.58
Resistance Level $37.93 $54.85
Average True Range (ATR) 1.05 2.72
MACD 0.31 -0.33
Stochastic Oscillator 95.54 21.50

Price Performance

Historical Comparison
AZTA
HROW

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: